Mirum Pharmaceuticals, Inc.
DE ˙ DB ˙ US6047491013
77,12 € ↑0,96 (1,26%)
2026-06-05
DEL PRIS
SecurityDE:08D / Mirum Pharmaceuticals, Inc.
InstitutionPanagora Asset Management Inc
Latest Disclosed Ownership129,114 shares
Latest Disclosed Value $ 11,927,551
Panagora Asset Management Inc ownership in 08D / Mirum Pharmaceuticals, Inc.

On May 14, 2026 - Panagora Asset Management Inc filed a 13F-HR form disclosing ownership of 129,114 shares of Mirum Pharmaceuticals, Inc. (DE:08D) valued at $9,683,550 USD as of March 31, 2026. The entity filed a previous 13F-HR on May 11, 2023 disclosing 0 shares of Mirum Pharmaceuticals, Inc.. The current value of the position is $9,957,272 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-14 2026-03-31 13F MIRUM PHARMACEUTICALS COM 604749101 129,114 129,114 11,928 0.0447
2023-05-11 2023-03-31 13F MIRUM PHARMACEUTICALS COM 604749101 0 -21,270 -100.00 0 -100.00
2023-02-13 2022-12-31 13F MIRUM PHARMACEUTICALS COM 604749101 21,270 -53,762 -71.65 415 -73.73 0.0027
2022-11-14 2022-09-30 13F MIRUM PHARMACEUTICALS COM 604749101 75,032 551 0.74 1,576 8.76 0.0109
2022-08-15 2022-06-30 13F MIRUM PHARMACEUTICALS COM 604749101 74,481 4,995 7.19 1,449 -5.29 0.0095
2022-05-12 2022-03-31 13F MIRUM PHARMACEUTICALS COM 604749101 69,486 2,427 3.62 1,530 42.99 0.0083
2022-02-10 2021-12-31 13F MIRUM PHARMACEUTICALS COM 604749101 67,059 39 0.06 1,070 -19.85 0.0057
2021-11-10 2021-09-30 13F MIRUM PHARMACEUTICALS COM 604749101 67,020 9,268 16.05 1,335 33.63 0.0071
2021-08-11 2021-06-30 13F MIRUM PHARMACEUTICALS COM 604749101 57,752 -141 -0.24 999 -12.90 0.0054
2021-05-12 2021-03-31 13F MIRUM PHARMACEUTICALS COMMON 604749101 57,893 36,724 173.48 1,147 210.00 0.0064
2021-02-10 2020-12-31 13F MIRUM PHARMACEUTICALS COMMON 604749101 21,169 21,169 370 0.0022
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.